Mary Riwes

952 total citations
33 papers, 516 citations indexed

About

Mary Riwes is a scholar working on Hematology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mary Riwes has authored 33 papers receiving a total of 516 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Hematology, 10 papers in Molecular Biology and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mary Riwes's work include Hematopoietic Stem Cell Transplantation (19 papers), Gut microbiota and health (7 papers) and Acute Myeloid Leukemia Research (5 papers). Mary Riwes is often cited by papers focused on Hematopoietic Stem Cell Transplantation (19 papers), Gut microbiota and health (7 papers) and Acute Myeloid Leukemia Research (5 papers). Mary Riwes collaborates with scholars based in United States, Japan and Netherlands. Mary Riwes's co-authors include Pavan Reddy, John Magenau, Attaphol Pawarode, Thomas Braun, Sung Won Choi, Brian Parkin, John R. Wingard, Israel Henig, Gregory A. Yanik and Charles A. Dinarello and has published in prestigious journals such as Nature Medicine, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Mary Riwes

30 papers receiving 511 citations

Peers

Mary Riwes

HEMAT

IMMUN

ONCOL

Mixue Xie China

Daniel Peltier United States

Ryusuke Nabeshima Japan

Toshiro Kurokawa Japan

Yasutaka Kakinoki Japan

Mayuko Tamura Japan

S Okamura Japan

Mary Guckian United Kingdom

Marie‐Claude Gaudreau United States

Christian Genin France

Mixue Xie China

Mary Riwes

183 ×0.7

HEMAT

91 ×0.5

132 ×0.8

IMMUN

152 ×1.2

ONCOL

63 ×0.9

Citations per year, relative to Mary Riwes Mary Riwes (= 1×) peers Mixue Xie

Countries citing papers authored by Mary Riwes

Since Specialization

Citations

This map shows the geographic impact of Mary Riwes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary Riwes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary Riwes more than expected).

Fields of papers citing papers by Mary Riwes

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary Riwes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary Riwes. The network helps show where Mary Riwes may publish in the future.

Co-authorship network of co-authors of Mary Riwes

This figure shows the co-authorship network connecting the top 25 collaborators of Mary Riwes. A scholar is included among the top collaborators of Mary Riwes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary Riwes. Mary Riwes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Magenau, John, David Frame, Mary Riwes, et al.. (2025). PD-1 inhibition for relapse after allogeneic transplantation in acute myeloid leukemia and myelodysplastic syndrome. Blood Advances. 9(15). 3878–3886. 1 indexed citations

Frame, David, Sarah Anand, Sung Won Choi, et al.. (2024). Comparing 2-day vs 3-day flu-CY lymphodepleting regimens for CD19 CAR T-cell therapy in patients with non-hodgkin’s lymphoma. Frontiers in Immunology. 15. 1403145–1403145. 5 indexed citations

Riwes, Mary, Jonathan L. Golob, John Magenau, et al.. (2023). Rational Modification of Human Gut Microbiome and Metabolites By Dietary Resistant Starch in Allogeneic Hematopoietic Stem Cell Transplantation: A Feasibility Study. Blood. 142(Supplement 1). 2190–2190. 1 indexed citations

Riwes, Mary, Jonathan L. Golob, John Magenau, et al.. (2023). Feasibility of a dietary intervention to modify gut microbial metabolism in patients with hematopoietic stem cell transplantation. Nature Medicine. 29(11). 2805–2813. 17 indexed citations

Reddy, Pavan, John Magenau, Attaphol Pawarode, et al.. (2021). Characterizing advance care planning, palliative care utilization, and location of end-of-life for adult allogeneic hematopoietic stem cell transplant recipients.. Journal of Clinical Oncology. 39(15_suppl). 7034–7034.

Magenau, John, Daniel Peltier, Mary Riwes, et al.. (2021). Type 1 interferon to prevent leukemia relapse after allogeneic transplantation. Blood Advances. 5(23). 5047–5056. 16 indexed citations

Riwes, Mary, et al.. (2020). Short chain fatty acids: Postbiotics/metabolites and graft versus host disease colitis. Seminars in Hematology. 57(1). 1–6. 32 indexed citations

Zheng, Pan, Yang Liu, Hegang Chen, et al.. (2020). Targeting Danger Associated Molecular Pattern (DAMP) with CD24Fc to Reduce Acute Gvhd: Study Design on a Randomized Double Blind Placebo Controlled Phase III Clinical Trial (CATHY Study). Biology of Blood and Marrow Transplantation. 26(3). S180–S181. 4 indexed citations

D’Souza, Anita, Parameswaran Hari, Marcelo C. Pasquini, et al.. (2019). A Phase 2 Study of Pembrolizumab during Lymphodepletion after Autologous Hematopoietic Cell Transplantation for Multiple Myeloma. Biology of Blood and Marrow Transplantation. 25(8). 1492–1497. 24 indexed citations

10.

Raser, Kadee J., et al.. (2019). Effect of Methylphenidate and Duloxetine on Neurotoxicity in CAR-T: A Case Study. Biology of Blood and Marrow Transplantation. 25(3). S335–S336. 1 indexed citations

11.

Riwes, Mary, Alexander C. Schmidt, Thomas Braun, et al.. (2019). Rational Modification of Intestinal Microbiome and Metabolites after Allogeneic Hematopoietic Stem Cell Transplantation with Resistant Starch: A Pilot Study. Blood. 134(Supplement_1). 3276–3276. 2 indexed citations

12.

Magenau, John, Steven C. Goldstein, Robert J. Soiffer, et al.. (2018). α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease. Blood. 131(12). 1372–1379. 83 indexed citations

13.

Fujiwara, Hideaki, Melissa D. Docampo, Mary Riwes, et al.. (2018). Microbial metabolite sensor GPR43 controls severity of experimental GVHD. Nature Communications. 9(1). 3674–3674. 109 indexed citations

14.

Toubai, Tomomi, Corinne Rossi, Isao Tawara, et al.. (2018). Murine Models of Steroid Refractory Graft-versus-Host Disease. Scientific Reports. 8(1). 12475–12475. 16 indexed citations

15.

Pawarode, Attaphol, Anita D’Souza, Marcelo C. Pasquini, et al.. (2017). Phase 2 Study of Pembrolizumab during Lymphodepleted State after Autologous Hematopoietic Cell Transplantation in Multiple Myeloma Patients. Blood. 130. 339–339. 6 indexed citations

16.

Riwes, Mary, et al.. (2017). Microbial metabolites and graft versus host disease. American Journal of Transplantation. 18(1). 23–29. 33 indexed citations

17.

Riwes, Mary, Helen Leather, Dan Neal, et al.. (2016). Association of mannose-binding lectin levels and invasive fungal disease in hematologic malignancy patients receiving myelosuppressive chemotherapy or allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplantation. 51(9). 1228–1232. 5 indexed citations

18.

Miller, Holly, Thomas Braun, Terri Stillwell, et al.. (2016). Infectious Risk after Allogeneic Hematopoietic Cell Transplantation Complicated by Acute Graft-versus-Host Disease. Biology of Blood and Marrow Transplantation. 23(3). 522–528. 39 indexed citations

19.

Magenau, John, Thomas Braun, Pavan Reddy, et al.. (2015). Allogeneic transplantation with myeloablative FluBu4 conditioning improves survival compared to reduced intensity FluBu2 conditioning for acute myeloid leukemia in remission. Annals of Hematology. 94(6). 1033–1041. 8 indexed citations

20.

Riwes, Mary & John R. Wingard. (2012). Diagnostic methods for invasive fungal diseases in patients with hematologic malignancies. Expert Review of Hematology. 5(6). 661–669. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact